# FDA Inspection 671386 - Philip NMI Raskin - June 23, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/philip-nmi-raskin/3fa0553a-04f0-48e6-8af1-6f13a0b29dc9
Source feed: FDA_Inspections

> FDA Inspection 671386 for Philip NMI Raskin on June 23, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 671386
- Company Name: Philip NMI Raskin
- Inspection Date: 2010-06-23
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1226830 - 2024-01-11](https://www.globalkeysolutions.net/records/fda_inspections/philip-nmi-raskin/5cbf0401-1e36-4b28-bc06-065b131fcd3e)
- [FDA Inspection 1130798 - 2020-09-04](https://www.globalkeysolutions.net/records/fda_inspections/philip-nmi-raskin/3292ce3d-e66d-471f-8100-3428c953e940)
- [FDA Inspection 1041550 - 2018-02-20](https://www.globalkeysolutions.net/records/fda_inspections/philip-nmi-raskin/779f9eca-7e9d-4191-b479-a8f527415e82)

Company: https://www.globalkeysolutions.net/companies/philip-nmi-raskin/9074ba12-52ed-4918-8a4e-7fbcab7f7974

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c